Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Cutaneous Systemic Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT03398837
What this trial is testing

Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Corbus Pharmaceuticals Inc. 365
Testing effectiveness (Phase 2)Looking for participantsNCT06375005
What this trial is testing

Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, Zhejiang University, School of Medicine 38
Testing effectiveness (Phase 2)Looking for participantsNCT07287670
What this trial is testing

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Mediar Therapeutics 85
Early research (Phase 1)Ended earlyNCT04948554
What this trial is testing

MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002)

Who this might be right for
Systemic Sclerosis With and Without Interstitial Lung Disease
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 5
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Not applicableStudy completedNCT04411498
What this trial is testing

Effects of Fibromyalgia Syndrome in Patients With Systemic Sclerosis

Who this might be right for
Systemic SclerosisFibromyalgia
Antalya Training and Research Hospital 140
Testing effectiveness (Phase 2)Ended earlyNCT04680975
What this trial is testing

Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 10
Testing effectiveness (Phase 2)Study completedNCT01538719
What this trial is testing

IL1-TRAP, Rilonacept, in Systemic Sclerosis

Who this might be right for
SclerodermaSystemic SclerosisDiffuse Scleroderma+1 more
Boston University 24
Testing effectiveness (Phase 2)WithdrawnNCT04138485
What this trial is testing

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring
Not applicableAvailableNCT04432545
What this trial is testing

Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement

Who this might be right for
Systemic Sclerosis PulmonaryPulmonary HypertensionPulmonary Fibrosis
Universidad de la Sabana
Testing effectiveness (Phase 2)Temporarily pausedNCT04166552
What this trial is testing

Evaluation of Safety, Tolerability and Preliminary Efficacy of EHP-101 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Emerald Health Pharmaceuticals 36
Large-scale testing (Phase 3)UnknownNCT01586663
What this trial is testing

Serial Night Time Position Splint on Systemic Sclerosis

Who this might be right for
Diffuse Systemic Sclerosis
Federal University of São Paulo 76
Testing effectiveness (Phase 2)Looking for participantsNCT06470048
What this trial is testing

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT03222492
What this trial is testing

Brentuximab Vedotin for Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerodermadcSSc
National Institute of Allergy and Infectious Diseases (NIAID) 17
Testing effectiveness (Phase 2)Ended earlyNCT05626751
What this trial is testing

An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc)

Who this might be right for
Diffuse Cutaneous Systemic SclerosisSclerosis, Systemic
Amgen 174
Early research (Phase 1)Not Yet RecruitingNCT07439029
What this trial is testing

YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Diffuse Systemic SclerosisIdiopathic Inflammatory Myopathies (IIMs)+3 more
Children's Hospital of Fudan University 12
Testing effectiveness (Phase 2)WithdrawnNCT02166229
What this trial is testing

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Who this might be right for
SclerodermaSystemic Sclerosis
Yale University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Not applicableEnded earlyNCT00476697
What this trial is testing

UVA1 Light for Scleroderma and Similar Conditions

Who this might be right for
KeloidSclerodermaScars+2 more
University of Michigan 23
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Next Page